IMAB Forex-Nachrichten
I-Mab Inks Partnership With Bristol Myers Squibb To Evaluate Givastomig In Combination Study
Biotech company I-Mab (IMAB) announced Wednesday that it has entered into a clinical trial collaboration and supply agreement with Bristol Myers Squibb (BMY).
RTTNews
|
vor 156 Tagen
